AbbVie : ABBV

All AbbVie Articles

579 Articles

Jon C. Ogg | Sep 12, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More

The top analyst upgrades, downgrades and initiations for Thursday included AbbVie, Ally Financial, Anthem, Caterpillar, CVS Health, Deere, Oracle, PayPal,…

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 4, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Camping World, Cleveland-Cliffs, Coupa, Dollar General, DuPont, Nike, Roku, StoneCo and More

The top analyst upgrades, downgrades and initiations for Wednesday included AbbVie, Camping World, Cleveland-Cliffs, Coupa Software, Dollar General, DuPont, Nike,…

Chris Lange | Aug 27, 2019 at 8:35 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Aug 26, 2019 at 7:40 AM EDT

5 Incredible Blue Chip Stocks With 6% or Higher Dividends

These five companies all pay at least a 6% dividend and offer a reasonable degree of safety. Even if a…

Jon C. Ogg | Aug 20, 2019 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

The included AbbVie, Beyond Meat, Bio-Rad Laboratories, Dell Technologies, HP, Jumia Technologies, Nabriva Therapeutics, PG&E, Salesforce.com and Sarepta Therapeutics.

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:40 AM EDT

Major Pharma Sees Rising Tide in Short Interest

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Aug 8, 2019 at 1:05 PM EDT

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas,…

Chris Lange | Jul 25, 2019 at 8:35 AM EDT

Short Sellers Up the Ante in Big Pharma

The July 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 11, 2019 at 9:45 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

Jon C. Ogg | Jun 26, 2019 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, ADM, Conoco, FedEx, Fox, Kinder Morgan, Lennar, Micron, Slack, Virtu and More

The top analyst upgrades, downgrades and initiations on Wednesday included AbbVie, Archer Daniels Midland, ConocoPhillips, FedEx, Fox, Kinder Morgan, Lennar,…

Chris Lange | Jun 26, 2019 at 8:30 AM EDT

Short Sellers Seek Direction on Big Pharma

The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 25, 2019 at 11:45 AM EDT

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan shares jumped on Tuesday after the company announced that it would be acquired by AbbVie in a cash and…

1 … 15 16 17 18 19 … 39

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More

Short Sellers Can’t Make Up Their Minds on Big Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Camping World, Cleveland-Cliffs, Coupa, Dollar General, DuPont, Nike, Roku, StoneCo and More

Big Pharma Sees a Rising Tide in Short Interest

5 Incredible Blue Chip Stocks With 6% or Higher Dividends

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: AbbVie, ADM, Conoco, FedEx, Fox, Kinder Morgan, Lennar, Micron, Slack, Virtu and More

Short Sellers Seek Direction on Big Pharma

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More

Short Sellers Can’t Make Up Their Minds on Big Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Camping World, Cleveland-Cliffs, Coupa, Dollar General, DuPont, Nike, Roku, StoneCo and More

Big Pharma Sees a Rising Tide in Short Interest

5 Incredible Blue Chip Stocks With 6% or Higher Dividends

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: AbbVie, ADM, Conoco, FedEx, Fox, Kinder Morgan, Lennar, Micron, Slack, Virtu and More

Short Sellers Seek Direction on Big Pharma

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Featured Reads

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It